AC Immune is a series c plus startup. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
AC Immune is a clinical-stage biopharmaceutical company discovering, designing and developing therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases with a focus on Alzheimer's disease.
Stage
series-c-plus
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky